Triple negative breast cancer (TNBC) is a heterogeneous subtype in which tumors lack ER, progesterone receptor and HER2/Neu amplification and therefore is difficult to treat with targeted therapies. Here, ERBB2 is linked to triple-negative breast carcinoma.